Product Launch Q4 / 2026

Discover our revolution in
non-invasive ICP assessment

We enable non-invasive intracranial pressure (ICP) assessment – fast, safe, and reliable. A breakthrough designed to transform how clinicians understand and monitor the brain. For better decisions when every second counts.

Our partners

What’s new about our ICP technology?

Using transmission ultrasound and a clinically validated algorithm, our technology provides a new, non-invasive way to monitor intracranial pressure.

Non-invasive ICP method

Eliminates risks associated with traditional invasive monitoring techniques, such as bleeding and infections.

Real Time Data Analysis

Instant neurological insights enable faster clinical decision-making when every second counts.

Intelligent AI Classifier

Developed and validated on real clinical data, our AI-based classifier transforms complex biosignals into reliable, actionable insight.
Product Launch Q4 / 2026

Smart. Compact. Easy to Use.

A stand-alone device for non-invasive intracranial pressure (ICP) assessment
Our device provides real-time, non-invasive results, if intracranial pressure is elevated or normal – without the need for invasive probes or additional monitoring systems.

It captures and analyzes ultrasound-based signals through a clinically validated and released algorithm, delivering consistent and clinically relevant information at the bedside.

Designed as a compact, stand-alone solution, it integrates seamlessly into existing clinical workflows.

The hidden danger of undetected brain pressure

Mil/year

Global TBI cases

%

Complications of invasive ICP monitoring

$ billion

Total annual societal costs of TBI in the US

%

of invasive ICP procedures would be avoidable
TBI can affect anyone
Traumatic brain injury (TBI) affects millions globally, striking people of all ages, in any situation. Often caused by accidents or medical conditions, TBI can lead to elevated intracranial pressure (ICP), a critical and potentially fatal condition requiring urgent care.

Life-threatening risks
ICP is currently measured using invasive probes placed inside the skull. These procedures carry risks and are typically reserved for severe cases, leaving many patients undiagnosed when pressure changes may already be life-threatening.
Diagnosis possibilities limited
Only a few hospitals have neurosurgical capabilities. Clinicians must quickly decide whether to transfer a patient – often without reliable data. Worse, 50% of invasive would not have been needed, if non-invasive assessment is available.

Our solution
Our company was founded to change this — by developing a clinically validated, non-invasive solution for ICP assessment that enables earlier diagnosis, broader patient access, and safer neurological care.

How Sonovum solves today's ICP challenges

Comparison: Invasive ICP Assessment vs. Sonovum's Non-Invasive ICP Assessment

Conventional: Invasive

Sonovum: Non-Invasive

Surgical Risk

  • Associated with significant risks such as infection, bleeding, and tissue injury

No Procedural Risk

  • No procedural risk – entirely non-invasive

Limited Availability

  • Only available in highly specialized clinics worldwide

Maximum Availability

  • Designed for use in all clinics and even in pre-hospital environments

High Cost

  • High procedural and hospitalization costs due to surgery, invasive monitoring, and complications

Low Cost

  • No surgical or intensive-care costs – potential for significant healthcare cost reduction.

Delayed Decision Making

  • Delayed data availability – often limited to severe cases and specific units

Fast Insight

  • Provides instant, on-site insight into intracranial dynamics, supporting faster and safer clinical decisions.

Guided by Leading Clinicians

Our Medical Advisory Board and Key Opinion Leaders bring together internationally recognized experts in neurosurgery, intensive care, and neurology – ensuring that our development is driven by real clinical needs and evidence-based insight.

Bernhard Meyer, MD

Chairman of the Department of Neurosurgery 

Peter Vajkoczy, MD

Chairman of the Department of Neurosurgery

Karl Schaller, MD

Chairman of the Department of Neurosurgery

Andreas Hetzel, MD

Chairman of the Department of Neurology

First Application:
Traumatic Brain Injury

Our first clinical application focuses on patients with traumatic brain injury (TBI), providing a non-invasive way to assess intracranial pressure and avoid unnecessary invasive probes that carry risk of complications.

Possible fields of application

Our technology opens the door to a new chapter of neurosurgical care through non-invasive brain monitoring, with the potential to improve neurological ICP assessment across a wide range of field scenarios. Every new application will follow a path of careful research, clinical validation, and regulatory approval.

Ambulance Car

Enabling non-invasive ICP assessment in the ambulance to support faster and more informed transfer decisions, when every second counts.

Emergency Room

Supporting fast and reliable neurological assessment in the emergency room to guide critical treatment decisions.

Intensive Care Units (ICU)

Providing continuous or intermittent, non-invasive monitoring of intracranial pressure to support safer and more informed management in intensive care.

Sports

Rapid on-site assessment evaluation following head impacts, ideal for high-risk sports such as American football, Rugby, Skiing, or Boxing.

Military & Field Use

Real-time ICP assessment under extreme conditions, from blast injuries to triage of unconscious patients.

Ready to revolutionize brain monitoring?

Join us for better insights. better decisions.
Revolution of ICP
AI-driven brain diagnostics you can trust. Making brain monitoring simple, fast, and clinically meaningful.
Subscribe to our newsletter
© 2025 Sonovum. All rights reserved.